Unspecified

Verify with FDA CVM →

336 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
336
Total Reports
31
Deaths Reported
920.0%
Death Rate

Active Ingredients

Unspecified

Administration Routes

UnknownOralTopicalNasalIntravenousParenteralSubcutaneousAuricular (Otic)IntramuscularIntra-Articular

Species Affected

Dog 265
Cat 56
Cattle 8
Unknown 4
Chicken 1
Pig 1
Horse 1

Most Affected Breeds

Retriever - Labrador 41
Domestic Shorthair 38
Crossbred Canine/dog 34
Beagle 17
Chihuahua 13
Terrier - Bull - American Pit 12
Dachshund (unspecified) 12
Shih Tzu 11
Dog (unknown) 9
Shepherd Dog - German 9

Most Reported Reactions

Vomiting 56
Not eating 33
Lethargy (see also Central nervous system depression in 'Neurological') 32
Quiet 29
Behavioural disorder NOS 28
Lack of efficacy - NOS 26
Vocalisation 25
Polydipsia 23
Diarrhoea 23
Panting 22
Bruising 22
Elevated serum alkaline phosphatase (ALP) 22

Outcome Breakdown

Outcome Unknown
130 (38.6%)
Ongoing
105 (31.2%)
Recovered/Normal
65 (19.3%)
Died
22 (6.5%)
Euthanized
9 (2.7%)
Recovered with Sequela
6 (1.8%)

Data Summary

Metric Value
Total adverse event reports 336
Reports involving death 31
Case-fatality rate (reported events) 920.0%
Distinct species in reports 7
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Unspecified Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 336 adverse event reports referencing Unspecified, including 31 reports in which the animal died — a 920.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Unspecified. Reported administration routes include Unknown, Oral, Topical, Nasal. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Unspecified reports are Dog (265 reports), Cat (56 reports), Cattle (8 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (41), Domestic Shorthair (38), Crossbred Canine/dog (34) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Unspecified are Vomiting (56), Not eating (33), Lethargy (see also Central nervous system depression in 'Neurological') (32), Quiet (29). Of the 337 reports with a coded outcome, Outcome Unknown is the leading category at 38.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Unspecified.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial